Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | BCL9 | O00512 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | MC4R | P32245 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HGFAC | Q04756 | 1/20 | 0.40 |
| ▸ | Q9HBH1 | 1/20 | 0.40 | |
| ▸ | PTPN7 | P35236 | 1/20 | 0.40 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8740500 | 1.00 | MMP2 (0.53) | MMP2MAPTCRHBPCRHR2L3MBTL1 | |
| SCHEMBL4423862 | 1.00 | MMP2 (0.53) | MMP2MAPTCRHBPCRHR2L3MBTL1 | |
| SCHEMBL28783978 | 0.90 | MMP2 (0.49) | MMP2MAPTCRHBPCRHR2L3MBTL1 | |
| SCHEMBL9840744 | 0.82 | BCL9 (0.50) | MAPTCRHBPCRHR2L3MBTL1BCL9 | |
| SCHEMBL7275811 | 0.82 | BCL9 (0.50) | MAPTCRHBPCRHR2L3MBTL1BCL9 | |
| SCHEMBL28323255 | 0.81 | BCL9 (0.51) | MAPTCRHBPCRHR2BCL9CTNNB1 | |
| SCHEMBL712246 | 0.81 | MMP2 (0.46) | MMP2MAPTKMT2AALDH1A1 | |
| SCHEMBL18941468 | 0.81 | PDF (0.48) | MMP2MAPTCRHBPCRHR2L3MBTL1 | |
| SCHEMBL18941467 | 0.81 | PDF (0.48) | MMP2MAPTCRHBPCRHR2L3MBTL1 | |
| SCHEMBL9819573 | 0.81 | BCL9 (0.47) | MMP2MAPTCRHBPCRHR2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083142-A1 | DRIED FLAKES WITH ACTIVE INGREDIENTS | FLAVORSENSE (US) | 2026-03-26 | — | — | US | disclosed |
| US-12310379-B2 | Dried flakes with active ingredients | FLAVORSENSE (US) | 2025-05-27 | — | — | US | disclosed |
| US-12168030-B2 | Method for producing stable Actinidia deliciosa powder with high level bioactive actinidin enzyme | WAITAKI BIOSCIENCES (NZ) | 2024-12-17 | — | — | US | disclosed |
| CN-117582521-A | therapeutic dendrimers | 阿斯利康(瑞典)有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20230292797-A1 | DRIED FLAKES WITH ACTIVE INGREDIENTS | FLAVORSENSE | 2023-09-21 | — | — | US | disclosed |
| US-11533936-B2 | Dried flakes with active ingredients | FLAVORSENSE (US) | 2022-12-27 | — | — | US | disclosed |
| EP-4099841-A1 | METHOD FOR PRODUCING STABLE ACTINIDIA DELICIOSA POWDER WITH HIGH LEVEL BIOACTIVE ACTINIDIN ENZYME | Waitaki Biosciences (NZ) | 2022-12-14 | — | — | EP | disclosed |
| US-8017557-B2 | Moderate protein hydrolyzates in plants | ENDURA S.P.A. (IT) | 2011-09-13 | — | — | US | disclosed |
| EP-1511382-B1 | BENZODIOXOLE DERIVATIVES AS MODULATORS OF THE PROTEOLYTIC ACTIVITY IN PLANTS | ENDURA SPA (IT) | 2006-04-12 | — | — | EP | disclosed |
| US-20050085390-A1 | Benzodioxole derivatives as modulators of proteolytic activity in plants | ENDURA S.P.A. (IT) | 2005-04-21 | — | — | US | disclosed |
| EP-1511382-A1 | BENZODIOXOLE DERIVATIVES AS MODULATORS OF THE PROTEOLYTIC ACTIVITY IN PLANTS | ENDURA S.p.A. (IT) | 2005-03-09 | — | — | EP | disclosed |
| WO-2003067985-A1 | BENZODIOXOLE DERIVATIVES AS MODULATORS OF THE PROTEOLYTIC ACTIVITY IN PLANTS | ENDURA S.P.A. (IT) | 2003-08-21 | — | — | WO | disclosed |
| EP-0636028-A4 | SELF-ASSEMBLING POLYNUCLEOTIDE DELIVERY SYSTEM. | UNIV CALIFORNIA (US) | 1998-12-09 | — | — | EP | disclosed |
| EP-0715619-A4 | INHIBITORS OF TNF-ALPHA SECRETION | IMMUNEX CORP (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0715619-A1 | INHIBITORS OF TNF-ALPHA SECRETION | IMMUNEX CORPORATION (US) | 1996-06-12 | — | — | EP | disclosed |
| EP-0636028-A1 | SELF-ASSEMBLING POLYNUCLEOTIDE DELIVERY SYSTEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-02-01 | — | — | EP | disclosed |
| WO-1993019768-A1 | SELF-ASSEMBLING POLYNUCLEOTIDE DELIVERY SYSTEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-10-14 | — | — | WO | disclosed |
| EP-0002677-B1 | GLUCOSAMINE-PEPTIDE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS | Takeda Chemical Industries, Ltd. (JP) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083142-A1 | DRIED FLAKES WITH ACTIVE INGREDIENTS | COG1, COG5, COG3 | MMP2 3689/4885MAPT 445/4885CRHBP 3714/4885 |
| US-20050085390-A1 | Benzodioxole derivatives as modulators of proteolytic activity in plants | BBOX1, BROX, PEPD | MMP2 20/4885MAPT 3823/4885CRHBP 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.